Hence, it is plausible that SPHK upregulation dominated T2D pregnancies and pregnancies associated with fetal macrosomia, i.e., pregnancies characterized by high fetal and/or maternal insulin levels in addition to hyperglycemia. The gene discussed is SPHK1; the disease is type 2 diabetes mellitus.